CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Impact of 68 Ga-PSMA-11 PET on the Management of biochemically recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
DOI 10.1055/s-0040-1708125
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Ferdinandus, WP Fendler, J Calais, M Eiber, RR Flavell, A Mishoe, FY Feng, HG Nguyen, RE Reiter, MB Rettig, J Gartmann, R Smith, EJ Small, R Slavik, PR Carroll, K Herrmann, J Czernin, TA Hope
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
Impact of 68 Ga-PSMA-11 PET on the Management of biochemically recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
Zitieren
Zitierempfehlung
J Ferdinandus, WP Fendler, J Calais, M Eiber, RR Flavell, A Mishoe, FY Feng, HG Nguyen, RE Reiter, MB Rettig, J Gartmann, R Smith, EJ Small, R Slavik, PR Carroll, K Herrmann, J Czernin, TA Hope (2020) Impact of 68 Ga-PSMA-11 PET on the Management of biochemically recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708125
Mit CareLit weiterarbeiten